Consensus Fund of Funds

Consensus Fund of Funds is a London-based principal investment firm that specializes in venture capital and private equity investments. Established in 2001 as a subsidiary of Consensus Business Group, the firm targets various stages of development, from start-ups to pre-IPO ventures. It focuses on a diverse array of sectors including buy-outs, technology, life sciences, environmental services, media, and industrial services. Consensus Fund of Funds seeks investment opportunities that present synergies with its existing portfolio, allowing for strategic growth and alignment with its overarching investment goals. With a commitment to identifying high-potential fund opportunities, the firm operates primarily within the United Kingdom, leveraging its expertise to navigate the complexities of the investment landscape effectively.

Mark Sandiforth

Acqusitions Director

15 past transactions

TripleW Ltd.

Series B in 2021
3PLW commercializes a proprietary bioprocess for production of 100% recycled bioplastic utilizing organic waste as feedstock. Current market adoption of bioplastic is hindered by the costs associated with purchase of feedstock sugar derived from major crops. By utilizing waste as feedstock and as a revenue source, the company can significantly decrease production costs of bioplastics

MEDX Xelerator

Funding Round in 2021
MEDX Xelerator is a unique medical device and digital health incubator. It was founded by MEDX Ventures Group, together with three partners: Boston Scientific, Intellectual Ventures’ Invention Science Fund and Sheba Medical Center. Each of MEDX Xelerator’s partners contributes outstanding core competencies, which complement one another and together create a solid foundation for your success. Our incubator is seeking medical innovations for minimally invasive procedures, medical robotics, medical implants and digital health. Our vision is to leverage the power of MEDX Xelerator, and together with the extraordinary Israeli med tech innovation scene create a local cluster of entrepreneurial companies with breakthrough solutions to true unmet medical needs. Our mission is to nurture those promising technologies into successful medical ventures for the benefit of patients and health care professionals. We see you, the entrepreneur, as the key to success and we are here for you to make it happen.

FlexDex

Venture Round in 2021
FlexDex is a minimally invasive surgery medical device technology that provides high dexterity. Its platform technology translates the surgeon’s hand, wrist, and arm movements from outside the patient into corresponding movements of an end-effector inside the patient’s body. The company was founded in 2010 and is headquartered in Brighton, Michigan.

Cynerio

Series B in 2021
Cynerio develops a platform that enables healthcare providers to secure patient data and connected medical devices against cyber threats. Its platform provides device behavior learning with medical workflow analysis to provide full visibility of what devices are doing on the network and associated risk, detecting anomalous activity, and stopping the threat. Daniel Brodie and Leon Lerman founded Cynerio in 2017.Its headquarters is in Tel Aviv in Israel.

Phytolon

Funding Round in 2020
Phytolon is a food and beverage company that offers a technology designed for the production of natural food colorants using bakers yeast cells as bio-factory. It specializes in fermentation to create a natural food colorant.

SCL

Venture Round in 2005
SCL Group Limited operates as a strategy and communications agency that engages in the creation, implementation, and evaluation of behavioral research and strategic communication campaigns for brands, political organizations, governments, and military organizations worldwide. It offers research and strategy, IT and infrastructure solutions, capacity building, communications, consultancy, and training services; and predictive data analytics, psychographic profiling, messages and marketing campaigns to create insights and communication strategies. SCL Group Limited was incorporated in 2005 and is based in London, the United Kingdom.

CPower

Series B in 2009
CPower, Inc. offers energy conservation and management consulting services. The company’s suite provides revenue generation, energy conservation measurement, usage forecasting, and strategic consulting services. Its clientele include CB Richard Ellis, Equity Office Properties,Morgan Stanley, Macy’s, Starwood Hotels, Hines Property Management, Forest City Ratner Corporation, Co-op City, Macklowe Properties, RFR Realty, New York Presbyterian Hospital, Newmark Properties, Douglas Elliman Property Management, The State of Massachusetts’ Division of Capital Asset Management, Lenox Hill Hospital, Cooper Square Realty, University of Massachusetts, Amherst, and Wentworth Management. CPower, Inc. was formerly known as ConsumerPowerline, Inc. and changed its name in September, 2008. The company was founded in 2000 and is based in New York, New York.

BioProtect

Series D in 2020
BioProtect Ltd. is an international medical device startup. It is primarily engaged in to the business of developing and commercializing biodegradable balloon spacers for the protection of normal tissue during cancer radiation therapy. The company's current focus in the growing radiotherapy spacers market, where its ProSpace balloon spacer (CE marked) has shown superior efficacy and safety in protecting the rectum during radiation therapy for prostate cancer. The company's technology platform of biodegradable implantable balloons suits a wide range of applications for unmet clinical needs. BioProtect was founded in the year 2004 and headquartered in Israel, with subsidiaries in Germany and US.

Setpoint.ai

Seed Round in 2019
Zero Energy Solution is an emerging Israeli developer of smart & scalable energy solutions in the IOT ans AI arenas. We provide autonomous, easy installed room energy optimizers that connect energy consumers into one Energy Intelligence platform.Our easily installed sets of smart controllers and sensors are wirelessly connected to our smart cloud-based software. We use big-data analysis and sophisticated algorithms to automatically optimize energy consumption, while maintaining comfort.

BioProtect

Venture Round in 2023
BioProtect Ltd. is an international medical device startup. It is primarily engaged in to the business of developing and commercializing biodegradable balloon spacers for the protection of normal tissue during cancer radiation therapy. The company's current focus in the growing radiotherapy spacers market, where its ProSpace balloon spacer (CE marked) has shown superior efficacy and safety in protecting the rectum during radiation therapy for prostate cancer. The company's technology platform of biodegradable implantable balloons suits a wide range of applications for unmet clinical needs. BioProtect was founded in the year 2004 and headquartered in Israel, with subsidiaries in Germany and US.

BIOMx

Series B in 2019
BiomX discovers and develops innovative microbiome therapeutics. The Company's mission is to develop novel therapeutics for preventing and treating diseases in which microbiome imbalances have been implicated. BiomX's microbiome modulation technologies are based on the cutting-edge innovative research of its scientific collaborators: Professor Rotem Sorek, PhD and Dr. Eran Elinav, MD, PhD both of the Weizmann Institute of Science and Professor Timothy K. Lu, MD, PhD of the Massachusetts Institute of Technology.

NewRocket

Series A in 2020
NewRocket is developing advanced, environmentally friendly (“green propulsion”) rocket engines based on innovative gel-propellant.

Mercado

Venture Round in 2006
Mercado provides a commerce-specific search engine for online retailing. The company provides software used to manage e-commerce operations, including merchandising, searching, catalog management, and browsing functions. Mercado provides eCommerce professionals with a platform on which to execute merchandising strategies and drive revenue growth.

RepAir

Series A in 2022
RepAir develops a Direct Air Capture system based on a proprietary electrochemical cell technology that can capture CO2 from the air in gigaton scale. Powered solely by renewable energy, our system can be deployed at the site of carbon storage or utilizations, saving arable land and avoiding CO2 transport.

Exero Medical

Seed Round in 2021
Exero Medical is a medical device manufacturing company. It develops a biodegradable wireless sensor for early detection of anastomotic leaks following GI Surgery. Its system is designed to prevent complications by warning physicians of a potential leak, enabling early intervention. The company was founded in 2018 and is headquartered in Or Yehuda, Israel.